XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://biotechstocks.com/amgen-amgn-receives-positive-chmp-opinion-to-add-overall-survival-results-from-the-phase-3-aspire/20%Monthly2018-04-30 13:57
https://biotechstocks.com/cytori-therapeutics-inc-cytx-provides-update-on-us-manufacturing-and-eu-approval-plans-for-ati-0918-liposomal-doxorubicin/20%Monthly2018-04-30 13:52
https://biotechstocks.com/alder-biopharmaceuticals-inc-aldr-to-host-conference-call-to-discuss-first-quarter-2018-financial-and-operating-results/20%Monthly2018-04-30 13:50
https://biotechstocks.com/conatus-pharmaceuticals-inc-cnat-announces-completion-of-enrollment-in-encore-ph-phase-2b-clinical-trial-of-emricasan/20%Monthly2018-04-30 13:48
https://biotechstocks.com/celgene-corporation-celg-announces-appointment-of-jennifer-dudinak-to-senior-vice-president-of-global-regulatory-affairs/20%Monthly2018-04-30 13:41
https://biotechstocks.com/fda-clears-pluristem-therapeutics-inc-psti-radiation-treatment-for-emergency-use/20%Monthly2018-04-30 13:37
https://biotechstocks.com/alder-biopharmaceuticals-inc-aldr-appoints-jeremy-green-to-its-board-of-directors/20%Monthly2018-04-26 13:03
https://biotechstocks.com/seasoned-financial-executive-federica-obrien-joins-gt-biopharmas-gtbp-board-of-directors/20%Monthly2018-06-06 16:31
https://biotechstocks.com/u-s-fda-clears-pluristem-therapeutics-inc-psti-hase-iii-study-in-treatment-of-muscle-injury/20%Monthly2018-04-25 12:45
https://biotechstocks.com/former-sucampo-chief-scientific-officer-dr-peter-kiener-joins-gt-biopharmas-gtbp-board-of-directors/20%Monthly2018-06-06 16:32
https://biotechstocks.com/alder-biopharmaceuticals-inc-aldr-appoints-eric-carter-ph-d-m-d-as-interim-chief-medical-officer/20%Monthly2018-04-23 14:30
https://biotechstocks.com/advaxis-inc-adxs-executive-leadership-changes/20%Monthly2018-04-23 14:23
https://biotechstocks.com/vbi-vaccines-inc-vbiv-announced-dosing-of-last-patient-in-protect-phase-3-clinical-study-for-sci-b-vac/20%Monthly2018-04-23 14:18
https://biotechstocks.com/biogen-biib-new-spinraza-data-unveiled-at-aan-annual-meeting/20%Monthly2018-04-23 13:50
https://biotechstocks.com/pluristem-therapeutics-inc-psti-and-indiana-university-to-initiate-joint-project-evaluating-plx-r18/20%Monthly2018-04-23 13:16
https://biotechstocks.com/vbi-vaccines-inc-vbiv-announces-completion-of-enrollment-in-protect-phase-3-clinical-study-for-sci-b-vac/20%Monthly2018-04-19 13:42
https://biotechstocks.com/vbi-vaccines-inc-vbiv-announces-positive-dsmb-review-in-phase-12a-study-of-vbi-1901/20%Monthly2018-04-17 13:29
https://biotechstocks.com/biogen-biib-builds-on-its-40-year-legacy-in-neuroscience/20%Monthly2018-04-17 13:27
https://biotechstocks.com/oncosec-medical-incorporated-oncs-provides-highlights-from-research-reception-at-aacr-annual-meeting-2018/20%Monthly2018-04-16 12:53
https://biotechstocks.com/bluebird-bio-inc-blue-to-present-at-alliance-for-regenerative-medicines-6th-annual-cell-gene-therapy-investor-day/20%Monthly2018-04-16 12:49
https://biotechstocks.com/neuralstem-inc-cur-to-present-clinical-update-at-the-alliance-for-regenerative-medicine-6th-annual-cell-gene-therapy-investor-day/20%Monthly2018-04-11 14:16
https://biotechstocks.com/halo-to-host-first-quarter-2018-financial-results-conference-call/20%Monthly2018-04-10 12:38
https://biotechstocks.com/cur-announces-first-surgery-completed-in-cervical-cohort-of-phase-1-clinical-trial/20%Monthly2018-04-10 12:37
https://biotechstocks.com/gtbp-announces-it-has-completed-enrollment-in-proof-of-concept-clinical-trial-for-its-novel-treatment/20%Monthly2018-06-06 16:34
https://biotechstocks.com/protalex-inc-prtx-fourth-cohort-dosing-of-phase-12-study-of-prtx-100-in-immune-thrombocytopenia/20%Monthly2018-04-09 14:13
https://biotechstocks.com/conatus-pharmaceuticals-inc-cnat-announces-upcoming-oral-presentation-at-easl-annual-meeting/20%Monthly2018-04-09 14:05
https://biotechstocks.com/celgene-corporation-celg-to-announce-first-quarter-2018-results-on-may-04-2018/20%Monthly2018-04-09 13:52
https://biotechstocks.com/ptc-therapeutics-inc-nasdaqptct-and-chdi-foundation-inc-to-jointly-work-on-a-program-to-reduce-huntingtin-protein/20%Monthly2018-04-06 05:46
https://biotechstocks.com/boston-scientific-corporation-nysebsx-acquires-securus-medical-group-inc-for-40-million/20%Monthly2018-04-06 05:42
https://biotechstocks.com/eleven-biotherapeutics-inc-nasdaqebio-announces-q4-and-full-year-operating-results-for-2017/20%Monthly2018-04-06 05:41
https://biotechstocks.com/biogen-inc-biib-and-samsung-bioepis-agree-to-settlement-with-abbvie/20%Monthly2018-04-05 13:12
https://biotechstocks.com/ptc-therapeutics-inc-nasdaqptct-sets-the-price-for-public-offering-of-the-common-stock/20%Monthly2018-04-05 11:22
https://biotechstocks.com/alnylam-pharmaceuticals-inc-nasdaqalny-presents-the-clinical-outcome-of-an-investigational-rnai-therapeutic-givosiran/20%Monthly2018-04-05 11:21
https://biotechstocks.com/array-biopharma-inc-nasdaqarry-publishes-the-results-of-phase-3-trial-of-binimetinib-and-encorafenib-in-melanoma-patients/20%Monthly2018-04-05 11:20
https://biotechstocks.com/immunogen-inc-nasdaqimgn-announces-the-clinical-outcome-of-mirvetuximab-soravtansine-to-treat-epithelial-ovarian-cancer/20%Monthly2018-04-04 10:30
https://biotechstocks.com/zosano-pharma-corp-nasdaqzsan-fixes-the-price-for-the-sale-of-common-stock/20%Monthly2018-04-04 10:26
https://biotechstocks.com/pulmatrix-inc-nasdaqpulm-sets-the-price-of-an-underwtitten-public-offering/20%Monthly2018-04-04 10:25
https://biotechstocks.com/oncosec-medical-incorporated-oncs-host-research-reception-during-the-2018-american-association-of-cancer-research-annual-meeting/20%Monthly2018-04-03 12:50
https://biotechstocks.com/opko-health-inc-nasdaqopk-commences-phase-2b-trial-of-opk88003-by-recruiting-the-new-patient-for-the-treatment-of-type-2-diabetes/20%Monthly2018-04-03 07:34
https://biotechstocks.com/ipsen-a-partner-of-exelixis-inc-nasdaqexel-validates-a-new-application-for-cabometyx-to-treat-patients-who-were-treated-earlier-for-advanced-hepatocellular-carcinoma/20%Monthly2018-04-03 07:33
https://biotechstocks.com/biopharmx-corp-nyseamericanbpmx-gets-patent-protection-for-its-novel-delivery-system-from-the-u-s-patent-and-trademark-office/20%Monthly2018-04-03 07:31
https://biotechstocks.com/aytu-bioscience-inc-nasdaqaytu-allots-additional-2-million-shares-to-the-underwriters/20%Monthly2018-04-02 10:27
https://biotechstocks.com/ceo-chairman-of-sorrento-therapeutics-inc-nasdaqsrne-reassures-the-shareholders/20%Monthly2018-04-02 10:26
https://biotechstocks.com/amgen-inc-nasdaqamgn-gets-fda-nod-for-blincyto-to-cure-minimal-residual-disease/20%Monthly2018-04-02 10:24